Quantity: ~1M viable cells
CIRM Line ID: CW10130
Disease: Fatty Liver
Gender: Male
Sampled age: 36
Ethinicity: Asian

SKU: CH-SeV-CW10130 Categories: , , Tag:


Quantity: ~1M viable cells

CIRM Line ID: CW10130

Disease: Fatty Liver

Gender: Male

Sampled age: 36

Race: Asian

Donor data

Demographic (source: CIRM) Description FATTY LIVER DISEASE | DEFINITE NASH
Affected Status Yes
Product iPSC
Source PBMC
Sex Male
Age at Sampling 36 YR
Race Asian
Ethnicity Not Hispanic or Latino
Publications Cited 0
dbGap No
Biopsy Source Blood
Collection Liver Diseases
Cell Type Stem Cell
Tissue Type Induced pluripotent stem cell
Transformant Episomal
Species sapiens
Common Name human
Detailed Clinical Data false
Clinical data (source: CIRM) LiverDisordersNASH LiverDisordersNASH
Diagnosis Fatty Liver Disease
Body_Mass_Index 28.5
Hypertension No
Diabetes No
Hyperlipidemia Yes
Alcohol_Consumption None
HBsAg_negative Yes
HCV_antibody_negative Yes
ANA_or_IgG_result normal
Liver_biopsy_(year) 2014
Steatosis_score_(0-3) 2
Ballooning_score_(0-2) 1
Lobular_inflammation_score_(0-3) 1
NAS_score_(0-8) 4
Fibrosis_score_(0-4) 0
NASH_diagnosis_by_pathologist definite NASH
  • Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
  • All donor consents include statements on the following:
    • Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
    • Changing some of the genetic code or sequence within these cells
    • Using cells to test or select drugs to treat disease
    • Transplanting cells or resulting products to humans or animals

      Distributing cells widely (nationally and internationally) for research, training or commercial medical product development

    • Future research and uses unforeseen at this time
  • Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
  • Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.


Please refer this page for some characteristics data.